Cytotoxic necrotizing factor 1 (CNF1) from uropathogenic Escherichia coli belongs to a family of factors activating Rho GTPases. We report the in vivo effects of CNF1 in mice co-fed toxin and the soluble protein antigen ovalbumin (OVA). Similar to cholera toxin, CNF1 elicits adjuvanticity anti-OVA responses, both systemic and mucosal. In contrast, the catalytic inactive mutant CNF1-C866S demonstrated no effects. Using dermonecrotic toxin (DNT), a closely related Rho activating toxin from Bordetella, we discovered that the adjuvant property is within the DNT catalytic domain. Manipulation of Rho proteins thus provides a possible new approach for the development of effective mucosal immunoadjuvants
Abstract Nowadays, there is increasing evidence that some pathogenic bacteria can contribute to spec...
The Cytotoxic Necrotizing Factor 1 (CNF1) produced by uropathogenic Escherichia coli allows us to hi...
International audienceThe monitoring of the activation state of Rho GTPases has emerged as a potent ...
Cytotoxic necrotizing factor 1 (CNF1) from uropathogenic Escherichia coli belongs to a family of fac...
The CNF1 toxin is produced by some uropathogenic (UPECs) andmeningitis-causing Escherichia coli stra...
Some isolates of Yersinia pseudotuberculosis produce the cytotoxic necrotizing factor (CNFY), but th...
Cytotoxic necrotizing factor type 2 (CNF2)produced by Escherichia coli strains isolated from intesti...
Cytotoxic necrotizing factor 1 (CNF1), a 110-kDa protein toxin from pathogenic Escherichia coli indu...
There is a need to develop new effective immunoadjuvants for prophylactic or therapeutic vaccines ag...
<div><p>Some isolates of <i>Yersinia pseudotuberculosis</i> produce the cytotoxic necrotizing factor...
Cytotoxic necrotizing factor 1 (CNF1) is a bacterial virulence factor, the target of which is repres...
International audienceThere is a need to develop new effective immunoadjuvants for prophylactic or t...
International audienceAlterations of the cellular proteome over time due to spontaneous or toxin-med...
In this thesis we will explore the topic of cytotoxic necrotizing factors (CNFs) and show the creati...
<p>(<b>A</b>) J774A.1 macrophages were treated with 25 nM purified CNF<sub>Y</sub> toxin for 3 h. To...
Abstract Nowadays, there is increasing evidence that some pathogenic bacteria can contribute to spec...
The Cytotoxic Necrotizing Factor 1 (CNF1) produced by uropathogenic Escherichia coli allows us to hi...
International audienceThe monitoring of the activation state of Rho GTPases has emerged as a potent ...
Cytotoxic necrotizing factor 1 (CNF1) from uropathogenic Escherichia coli belongs to a family of fac...
The CNF1 toxin is produced by some uropathogenic (UPECs) andmeningitis-causing Escherichia coli stra...
Some isolates of Yersinia pseudotuberculosis produce the cytotoxic necrotizing factor (CNFY), but th...
Cytotoxic necrotizing factor type 2 (CNF2)produced by Escherichia coli strains isolated from intesti...
Cytotoxic necrotizing factor 1 (CNF1), a 110-kDa protein toxin from pathogenic Escherichia coli indu...
There is a need to develop new effective immunoadjuvants for prophylactic or therapeutic vaccines ag...
<div><p>Some isolates of <i>Yersinia pseudotuberculosis</i> produce the cytotoxic necrotizing factor...
Cytotoxic necrotizing factor 1 (CNF1) is a bacterial virulence factor, the target of which is repres...
International audienceThere is a need to develop new effective immunoadjuvants for prophylactic or t...
International audienceAlterations of the cellular proteome over time due to spontaneous or toxin-med...
In this thesis we will explore the topic of cytotoxic necrotizing factors (CNFs) and show the creati...
<p>(<b>A</b>) J774A.1 macrophages were treated with 25 nM purified CNF<sub>Y</sub> toxin for 3 h. To...
Abstract Nowadays, there is increasing evidence that some pathogenic bacteria can contribute to spec...
The Cytotoxic Necrotizing Factor 1 (CNF1) produced by uropathogenic Escherichia coli allows us to hi...
International audienceThe monitoring of the activation state of Rho GTPases has emerged as a potent ...